首页> 外文期刊>Genetics and Molecular Research >Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer
【24h】

Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer

机译:Fascin-1和Laminin-5在非小细胞肺癌中的临床意义

获取原文
           

摘要

Lung cancer is the leading cause of cancer death in men and the second leading cause of cancer death in women worldwide. Fascin-1 and laminin-5 were associated with the invasiveness and prognoses of several cancers. The expression and the serum levels of fascin-1 and laminin-5 in patients with non-small cell lung cancer (NSCLC) were analyzed in this study. The expression of fascin-1 and laminin-5 were examined in 378 patients and their serum level was measured in 154 patients. The health of all patients was followed post-surgery. The expression of fascin-1 (P = 0.000) and lanminin-5 (P = 0.001) and the serum levels of fascin-1 (P = 0.015) and laminin-5 (P = 0.046) were related to the relapse of patients with NSCLC. Both serum levels and expression of fascin-1 and laminin-5 can be used to effectively evaluate the prognoses of patients with NSCLC.
机译:肺癌是全球男性癌症死亡的主要原因,也是女性第二大癌症死亡的原因。 Fascin-1和laminin-5与几种癌症的侵袭性和预后有关。本研究分析了非小细胞肺癌(NSCLC)患者中fascin-1和laminin-5的表达和血清水平。检查378例患者中fascin-1和laminin-5的表达,并检测154例患者的血清水平。所有患者的健康均在手术后进行。 fascin-1(P = 0.000)和lanminin-5(P = 0.001)的表达以及fascin-1(P = 0.015)和laminin-5(P = 0.046)的血清水平与以下患者的复发有关非小细胞肺癌。血清水平和fascin-1和laminin-5的表达均可用于有效评估NSCLC患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号